4543 On Other Exchanges
Symbol
Exchange
4543 is not on other exchanges.

terumo corp (4543) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TERUMO CORP (4543)

Related News

No related news articles were found.

terumo corp (4543) Related Businessweek News

No Related Businessweek News Found

terumo corp (4543) Details

Terumo Corporation manufactures and sells medical devices and pharmaceuticals worldwide. It provides products in the areas of cardiovascular, hospital, and blood systems. The company offers vascular intervention devices, such as introducer sheathes, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems, including optical frequency domain imaging and intravascular ultrasound systems. It also provides interventional oncology devices, such as micro catheters and guide wires, micro balloon catheters, and drug-elutable beads; cardiopulmonary bypass systems comprising oxygenator with integrated arterial filters, heart-lung machines, and devices for percutaneous cardiopulmonary support system; and thoracic vascular and abdominal vascular grafts. In addition, the company offers infusion systems, including infusion pumps, closed infusion systems, and IV catheters; closed anticancer drug infusion systems; drugs and devices comprising prefilled syringes and pre-fillable syringes; pharmaceuticals and nutritional supplements; and peritoneal dialysis devices. Further, it provides analgesic and antiemetic pain management drugs; diabetes management devices; measuring device systems, such as blood glucose and blood pressure monitors, thermometers, pulse oximeters, and walking intensity and body composition monitors; and basal thermometers, fall prevention products, oral care products, urine test strips, and deodorizing devices. Additionally, the company offers automated blood collection and blood component processing systems, blood bag system with leukocyte reduction filters, pathogen reduction technology systems, centrifugal apheresis systems, cell expansion systems, and autologous cell processing devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.

20,697 Employees
Last Reported Date: 06/27/16
Founded in 1921

terumo corp (4543) Top Compensated Officers

Senior Executive Officer, Director, Chief Exe...
Total Annual Compensation: ¥168.0M
Compensation as of Fiscal Year 2016.

terumo corp (4543) Key Developments

Cytosorbents Teams with Japan-Based Terumo for Commercialization of Cytosorb in France and Scandinavia

Cytosorbents (CTSO) announced that it has entered into a multi-country strategic partnership with Japan-based Terumo Corporation to commercialize CytoSorb for cardiac surgery applications. Under the terms of the agreement, Terumo will have exclusive rights to distribute CytoSorb cardiopulmonary bypass procedure pack for intra-operative use during cardiac surgery in France, Sweden, Denmark, Norway, Finland and Iceland. Financial terms of the agreement were not disclosed.

Terumo Corporation Presents at Mizuho Investment Conference - Tokyo, Sep-12-2016

Terumo Corporation Presents at Mizuho Investment Conference - Tokyo, Sep-12-2016 . Venue: Prince Park Tower Hotel, 4-8-1, Shibakoen, Minato-ku, Tokyo 105-8563, Japan.

Terumo Corporation Provides Dividend Guidance for the Second Quarter of 2017; Provides Dividend Guidance for the Fourth Quarter Ending March 31, 2017

Terumo Corporation provided dividend guidance for the second quarter of 2017. For the quarter, the company expects to pay dividend of ¥20.00 per share against ¥19.00 per share a year ago. For the fourth quarter ending March 31, 2017, the company expects to pay dividend of ¥21.00 per share against ¥20.00 per share a year ago.

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4543 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4543.
View Industry Companies
 

Industry Analysis

4543

Industry Average

Valuation 4543 Industry Range
Price/Earnings 35.2x
Price/Sales 2.9x
Price/Book 3.1x
Price/Cash Flow 33.7x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TERUMO CORP, please visit www.terumo.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.